resiquimod has been researched along with Lymphopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bright, H; Burden, F; Colman, P; Corey, T; Fidock, M; Heyen, J; Horscroft, N; Khodai, T; Laxton, C; Mechiche, H; Perkins, H; Rawal, J; Rodrigues, D; Westby, M | 1 |
| Guyader, D; McHutchison, JG; Meng, TC; Patton, H; Pockros, PJ; Tong, MJ; Wright, T | 1 |
1 trial(s) available for resiquimod and Lymphopenia
| Article | Year |
|---|---|
Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.
Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fever; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Interferon-alpha; Leukocyte Count; Lymphocyte Count; Lymphopenia; Male; Middle Aged; Neutrophils; RNA, Viral; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome; Viral Load | 2007 |
1 other study(ies) available for resiquimod and Lymphopenia
| Article | Year |
|---|---|
Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model.
Topics: 2',5'-Oligoadenylate Synthetase; Aminoquinolines; Animals; Biomarkers; Blood Pressure; Chemokine CXCL10; Female; Heart Rate; Hypotension; Imidazoles; Interferon-alpha; Liver; Lymph Nodes; Lymphocyte Count; Lymphopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Quinolines; Sulfonamides; Toll-Like Receptor 7 | 2012 |